Former Horizon Technology Finance Managing Director Brings over 20
Years of Venture Debt Experience to Hercules
PALO ALTO, Calif.--(BUSINESS WIRE)--
Technology Growth Capital, Inc. (NYSE:HTGC) ("Hercules"), the
leading specialty financing provider to innovative venture growth stage
companies backed by leading venture capital firms, today announced the
appointment of Kristen Kosofsky as Senior Managing Director in the Life
Sciences Group in Hercules' Boston office.
"I am pleased to welcome Kristen to Hercules and to have such an
outstanding and seasoned investment professional join our
industry-leading originations team," stated Manuel A. Henriquez,
chairman and chief executive officer of Hercules. "Kristen's depth of
experience and life sciences industry knowledge, coupled with her strong
network is reflected in her proven track record of identifying, building
and managing a high quality life sciences portfolio. Kristen has the
right combination of skills to make significant contributions to our
originations team as we continue to expand and execute on our growth
plans in working with leading life sciences companies backed by some of
the most prominent venture capital firms. I am confident Kristen will
make numerous contributions to our company and our efforts to continue
to drive earnings and dividend growth."
Ms. Kosofsky is a seasoned executive, with more than 20 years of
experience in the venture debt market, focused on structuring financial
transactions for biotechnology, medical device and other healthcare and
select clean-tech related companies. Most recently, Ms. Kosofsky served
as Managing Director at Horizon Technology Finance, and was responsible
for business development in the life sciences market. Prior to Horizon,
Ms. Kosofsky served as Vice President, Life Sciences at Comerica Bank in
Boston and co-led the life sciences practice. Before joining Comerica,
Ms. Kosofsky worked in a number of finance and business development
roles at GATX Corporation and Transamerica Technology Finance. Ms.
Kosofsky began her career at Financing for Science International, Inc.
Ms. Kosofsky received a Bachelor of Science in Business from Central
Connecticut State University in New Britain, Connecticut.
About Hercules Technology Growth Capital, Inc.
Hercules Technology Growth Capital, Inc. (NYSE:HTGC) ("Hercules") is the
leading specialty finance company focused on providing senior secured
venture growth loans to high-growth, innovative venture capital-backed
companies in the technology, biotechnology, life sciences, healthcare,
and energy & renewable technology industries. Since inception (December
2003), Hercules has committed more than $5.6 billion to over 325
companies and is the lender of choice for entrepreneurs and venture
capital firms seeking growth capital financing. Companies interested in
learning more about financing opportunities should contact email@example.com,
or call 650.289.3060.
Hercules' common stock trades on the New York Stock Exchange (NYSE)
under the ticker symbol "HTGC."
In addition, Hercules has three outstanding bond issuances of 7.00%
Notes due April 2019, 7.00% Notes due September 2019, and 6.25% Notes
due July 2024, which trade on the NYSE under the symbols "HTGZ," "HTGY,"
and "HTGX," respectively.
The information disclosed in this press release is made as of the date
hereof and reflects Hercules' most current assessment of its historical
financial performance. Actual financial results filed with the SEC may
differ from those contained herein due to timing delays between the date
of this release and confirmation of final audit results. These
forward-looking statements are not guarantees of future performance and
are subject to uncertainties and other factors that could cause actual
results to differ materially from those expressed in the forward-looking
statements including, without limitation, the risks, uncertainties,
including the uncertainties surrounding the current market volatility,
and other factors the Company identifies from time to time in its
filings with the SEC. Although Hercules believes that the assumptions on
which these forward-looking statements are based are reasonable, any of
those assumptions could prove to be inaccurate and, as a result, the
forward-looking statements based on those assumptions also could be
incorrect. You should not place undue reliance on these forward-looking
statements. The forward-looking statements contained in this release are
made as of the date hereof, and Hercules assumes no obligation to update
the forward-looking statements for subsequent events.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151111005350/en/
Hercules Technology Growth Capital, Inc.
Michael Hara, 650-433-5578
Investor Relations and Corporate Communications
Mickey Mandelbaum, 310-785-0810
Source: Hercules Technology Growth Capital, Inc.
News Provided by Acquire Media